<DOC>
	<DOC>NCT01762397</DOC>
	<brief_summary>The Purpose of a randomized, double-blind, placebo-controlled, single-dose, dose-escalation clinical trial is to explore investigate the safety, tolerability, pharmacokinetics, and food effect of PMK-S005 after oral administration in healthy male volunteers.</brief_summary>
	<brief_title>A Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of PMK-S005 After Oral Administration in Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Gastritis</mesh_term>
	<mesh_term>Stomach Ulcer</mesh_term>
	<criteria>Male 20 year ≤ age ≤ 40 year. Weight ≥ 55kg, IBW ±20%. Patients with normal hematology, biochemistry, urinary result. Patients who have not congenital or chronic disease. Provision of written informed consent voluntarily. Patients having known hypersensitivity to any component of the study drug. Patients with a history of abnormal digestive organ, kidney, respiratory, neuroendocrine, cardiovascular, hematooncology, urinary, muscloskeletal, immune, the nose and ears, psychiatry, stomach system. Patients with any gastrointestinal disorders. Systolic blood pressure ≥ 150 or ≤ 90 mmHg, Diasolic blood pressure ≥ 95 or ≤ 50 mmHg. Drug abuser, alcoholic. Patients taking ETC medication within 14 days, OTC within 7 days. Patients taking other investigational product within 60 days prior to the participation in the study.</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>